Bio-Rad Labs (BIO) – StreetInsider.com Reports
-
Bio-Rad Labs (BIO) Chief Operating Officer Andrew Last to Retire
-
Citi Upgrades Sotera Health (SHC) to Buy
-
Citi Downgrades Bio-Rad Labs (BIO) to Neutral
-
Bio-Rad Labs (BIO) Appoints Roop K. Lakkaraju as CFO
-
Bio-Rad Labs (BIO) PT Raised to $420 at UBS
-
Bio-Rad Labs (BIO) Tops Q4 EPS by 28c; offers outlook
-
UBS Starts Bio-Rad Labs (BIO) at Buy
-
Bio-Rad Labs (BIO) PT Lowered to $460 at Wells Fargo
-
Bio-Rad Labs (BIO) PT Lowered to $482 at RBC Capital
-
Bio-Rad Labs (BIO) Misses Q3 EPS by 45c: provides outlook
-
Bio-Rad Labs (BIO) PT Lowered to $525 at Wells Fargo
-
Bio-Rad Labs (BIO) PT Raised to $524 at RBC Capital
-
Bio-Rad Labs (BIO) PT Lowered to $550 at Credit Suisse
-
Bio-Rad Labs (BIO) Tops Q2 EPS by 32c
-
Bio-Rad Labs (BIO) Announces $500M Share Buyback
-
Wells Fargo Resumes Bio-Rad Labs (BIO) at Overweight
-
Bio-Rad Labs (BIO) PT Lowered to $531 at RBC Capital
-
Bio-Rad Labs (BIO) PT Lowered to $525 at Citi
-
Bio-Rad Labs (BIO) PT Lowered to $580 at Credit Suisse
-
Bio-Rad Labs (BIO) Misses Q1 EPS by 46c
-
Top SMID cap stocks to own
-
Bio-Rad Labs (BIO) PT Raised to $615 at Jefferies
-
Bio-Rad Labs (BIO) PT Raised to $680 at Credit Suisse
-
Bio-Rad Labs (BIO) Misses Q4 EPS by 16c
-
Cytek Biosciences (CTKB) Partners with Bio-Rad to Expand Reagent Portfolios
-
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.80%
-
RBC Capital Starts Bio-Rad Labs (BIO) at Outperform
-
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95%
-
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95%
-
Bio-Rad Labs (BIO) halted on volatility
-
China, Hong Kong Stocks Rally Again on Fresh Reopening Rumors
-
Bio-Rad Labs (BIO) PT Lowered to $600 at Jefferies
-
Bio-Rad Labs (BIO) PT Lowered to $640 at Credit Suisse
-
Bio-Rad Labs (BIO) Misses Q3 EPS by 18c
-
3 Rumors Buzzing Around Wall Street Today
-
Bio-Rad Labs (BIO) and Qiagen (QGEN) in Combination Talks - WSJ
-
Bio-Rad Labs (BIO) call put ratio 10.4 calls to 1 put
-
Bio-Rad Labs (BIO) in Talks to Combine with Qiagen (QGEN) - WSJ
-
Credit Suisse Starts Bio-Rad Labs (BIO) at Outperform
-
Bio-Rad Labs (BIO) Acquires Curiosity Diagnostic for up to $170M
-
Bio-Rad Labs (BIO) Tops Q2 EPS by 58c
-
Thermo Fisher Scientific (TMO), Other Danaher (DHR) Peers Surge
-
Bio-Rad Labs (BIO) PT Lowered to $700 at Citi
-
Bio-Rad Labs (BIO) PT Lowered to $700 at Jefferies Despite Posting Upside
-
Bio-Rad Labs (BIO) Tops Q1 EPS by $1.54
-
Bio-Rad Labs (BIO) Investor Day Highlights Successful Turnaround, Next Comes Multiple Expansion - Jefferies
-
Bio-Rad Labs (BIO) Presents Growth Strategy and Acceleration of Financial Targets at Investor Day
-
Bio-Rad Labs (BIO) Files Mixed Shelf, Size not Specified
-
Bio-Rad Labs (BIO) PT Raised to $800 at Citi
-
Bio-Rad Labs (BIO) Tops Q4 EPS by 34c
Back to BIO Stock Lookup